A broad analysis of resistance development in the malaria parasite

被引：93

作者：

Corey, Victoria C. ^{[1
]}

Lukens, Amanda K. ^{[2
,3
]}

Istvan, Eva S. ^{[4
]}

Lee, Marcus C. S. ^{[5
]}

Franco, Virginia ^{[6
]}

Magistrado, Pamela ^{[2
]}

Coburn-Flynn, Olivia ^{[5
]}

Sakata-Kato, Tomoyo ^{[2
]}

Fuchs, Olivia ^{[1
]}

Gnadig, Nina F. ^{[5
]}

Goldgof, Greg ^{[1
]}

Linares, Maria ^{[6
]}

Gomez-Lorenzo, Maria G. ^{[6
]}

De Cozar, Cristina ^{[6
]}

Jose Lafuente-Monasterio, Maria ^{[6
]}

Prats, Sara ^{[6
]}

Meister, Stephan ^{[1
]}

Tanaseichuk, Olga ^{[7
]}

Wree, Melanie ^{[1
]}

Zhou, Yingyao ^{[7
]}

Willis, Paul A. ^{[8
]}

Gamo, Francisco-Javier ^{[6
]}

Goldberg, Daniel E. ^{[4
]}

Fidock, David A. ^{[5
]}

Wirth, Dyann F. ^{[2
,3
]}

Winzeler, Elizabeth A. ^{[1
]}

机构：

[1] Univ Calif San Diego, Sch Med, Dept Pediat, 9500 Gilman Dr 0741, La Jolla, CA 92093 USA

[2] Harvard Univ, TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA

[3] Broad Inst, Program Infect Dis, 415 Main St, Cambridge, MA 02142 USA

[4] Washington Univ, Sch Med, Dept Med & Microbiol, St Louis, MO 63110 USA

[5] Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, 630 W 168th St, New York, NY 10032 USA

[6] GlaxoSmithKline, Malaria DPU, Tres Cantos Med Dev Campus,Severo Ochoa 2, Madrid 28760, Spain

[7] Novartis Res Fdn, Genom Inst, 10675 John J Hopkins Dr, San Diego, CA 92121 USA

[8] Med Malaria Venture, POB 1826,20 Route Prebois, CH-1215 Geneva 15, Switzerland

来源：

NATURE COMMUNICATIONS | 2016年 / 7卷

关键词：

PLASMODIUM-FALCIPARUM; ARTEMISININ RESISTANCE; CLINICAL CANDIDATE; ANTIMALARIAL-DRUGS; DISCOVERY; VALIDATION; MUTATIONS; DIVERSITY; INVITRO; SITE;

D O I：

10.1038/ncomms11901

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Microbial resistance to chemotherapy has caused countless deaths where malaria is endemic. Chemotherapy may fail either due to pre-existing resistance or evolution of drug-resistant parasites. Here we use a diverse set of antimalarial compounds to investigate the acquisition of drug resistance and the degree of cross-resistance against common resistance alleles. We assess cross-resistance using a set of 15 parasite lines carrying resistance-conferring alleles in pfatp4, cytochrome bc(1), pfcarl, pfdhod, pfcrt, pfmdr, pfdhfr, cytoplasmic prolyl t-RNA synthetase or hsp90. Subsequently, we assess whether resistant parasites can be obtained after several rounds of drug selection. Twenty-three of the 48 in vitro selections result in resistant parasites, with time to resistance onset ranging from 15 to 300 days. Our data indicate that pre-existing resistance may not be a major hurdle for novel-target antimalarial candidates, and focusing our attention on fast-killing compounds may result in a slower onset of clinical resistance.

引用

页数：9

共 50 条

[21] Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator
Flegg, Jennifer A.
Guerin, Philippe J.
White, Nicholas J.
Stepniewska, Kasia
MALARIA JOURNAL, 2011, 10
[22] Chloroquine Transport via the Malaria Parasite's Chloroquine Resistance Transporter
Martin, Rowena E.
Marchetti, Rosa V.
Cowan, Anna I.
Howitt, Susan M.
Broeer, Stefan
Kirk, Kiaran
SCIENCE, 2009, 325 (5948) : 1680 - 1682
[23] Transfection technology and the study of drug resistance in the malaria parasite Plasmodium falciparum
Crabb, BS
DRUG RESISTANCE UPDATES, 2002, 5 (3-4) : 126 - 130
[24] Multistage inhibitors of the malaria parasite: Emerging hope for chemoprotection and malaria eradication
Poonam
Gupta, Yash
Gupta, Nikesh
Singh, Snigdha
Wu, Lidong
Chhikara, Bhupender Singh
Rawat, Manmeet
Rathi, Brijesh
MEDICINAL RESEARCH REVIEWS, 2018, 38 (05) : 1511 - 1535
[25] Malaria parasite mutants with altered erythrocyte permeability: a new drug resistance mechanism and important molecular tool
Hill, David A.
Desai, Sanjay A.
FUTURE MICROBIOLOGY, 2010, 5 (01) : 81 - 97
[26] Bridging the Gap in Malaria Parasite Resistance, Current Interventions, and the Way Forward from in Silico Perspective: A Review
Kumi, Ransford Oduro
Oti, Belinda
Abo-Dya, Nader E.
Alahmdi, Mohamed Issa
Soliman, Mahmoud E. S.
MOLECULES, 2022, 27 (22):
[27] Genomic Approaches to Drug Resistance in Malaria
Rocamora, Frances
Winzeler, Elizabeth A.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 74, 2020, 2020, 74 : 761 - 786
[28] A rapid and robust tri-color flow cytometry assay for monitoring malaria parasite development
Malleret, Benoit
Claser, Carla
Ong, Alice Soh Meoy
Suwanarusk, Rossarin
Sriprawat, Kanlaya
Howland, Shanshan Wu
Russell, Bruce
Nosten, Francois
Renia, Laurent
SCIENTIFIC REPORTS, 2011, 1
[29] A choline-releasing glycerophosphodiesterase essential for phosphatidylcholine biosynthesis and blood stage development in the malaria parasite
Ramaprasad, Abhinay
Burda, Paul-Christian
Calvani, Enrica
Sait, Aaron J.
Palma-Duran, Susana Alejandra
Withers-Martinez, Chrislaine
Hackett, Fiona
Macrae, James
Collinson, Lucy
Gilberger, Tim Wolf
Blackman, Michael J.
ELIFE, 2022, 11
[30] Resistance screening and trend analysis of imported falciparum malaria in NSW, Australia ( 2010 to 2016)
Prosser, Christiane
Meyer, Wieland
Ellis, John
Lee, Rogan
PLOS ONE, 2018, 13 (05):

← 1 2 3 4 5 →